help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Folkers, G. E.
Right arrow Articles by van der Saag, P. T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Folkers, G. E.
Right arrow Articles by van der Saag, P. T.

Molecular Endocrinology, Vol 7, 616-627, Copyright © 1993 by Endocrine Society


ARTICLES

The retinoic acid receptor-beta 2 contains two separate cell-specific transactivation domains, at the N-terminus and in the ligand-binding domain

GE Folkers, BJ van der Leede and PT van der Saag
Hubrecht Laboratory, Netherlands Institute for Developmental Biology, Utrecht.

In contrast to other members of the steroid/thyroid hormone superfamily, not much is known about the regions involved in transactivation of the receptors for retinoic acid. To determine the transactivation function of RARs, fusion proteins between the DNA- binding domain of the yeast transcription factor GAL4 and retinoic acid receptor-alpha (RAR alpha) or RAR beta were made. Transfection of these constructs resulted in RA-induced activation of a GAL4-responsive element-containing promoter. Deletion analysis revealed that RAR beta-2 has two transcription activation functions (TAFs). TAF-1 activates transcription constitutively and was mapped to the first 32 amino acids of the A-region. TAF-2 is located in the ligand-binding domain between amino acids 137 and 410 and activated transcription only in the presence of RA. The presence of two TAFs was confirmed by cotransfection of RAR beta deletion constructs with the human RAR beta- 2 promoter as reporter, showing that the absence of RAR beta TAF-1 causes a decrease in transactivation, whereas truncation of TAF-2 completely blocks this function. Internal deletions in the ligand- binding domain in both GAL-RAR beta and RAR beta expression constructs resulted in a nonfunctional receptor, indicating that the complete ligand-binding domain is required for its transactivation function. Furthermore, we have shown that the contribution of the two TAFs in transcription activation varies among different cell lines, suggesting that they act in a cell-specific manner.


This article has been cited by other articles:


Home page
Mol. Endocrinol.Home page
H. Tian, M. A. Mahajan, C. T. Wong, I. Habeos, and H. H. Samuels
The N-Terminal A/B Domain of the Thyroid Hormone Receptor-{beta}2 Isoform Influences Ligand-Dependent Recruitment of Coactivators to the Ligand-Binding Domain
Mol. Endocrinol., September 1, 2006; 20(9): 2036 - 2051.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. D. S. A. Wansa, J. M. Harris, G. Yan, P. Ordentlich, and G. E. O. Muscat
The AF-1 Domain of the Orphan Nuclear Receptor NOR-1 Mediates Trans-activation, Coactivator Recruitment, and Activation by the Purine Anti-metabolite 6-Mercaptopurine
J. Biol. Chem., June 27, 2003; 278(27): 24776 - 24790.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Oosterveen, P. van Vliet, J. Deschamps, and F. Meijlink
The Direct Context of a Hox Retinoic Acid Response Element Is Crucial for its Activity
J. Biol. Chem., June 20, 2003; 278(26): 24103 - 24107.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. D. S. A. Wansa, J. M. Harris, and G. E. O. Muscat
The Activation Function-1 Domain of Nur77/NR4A1 Mediates Trans-activation, Cell Specificity, and Coactivator Recruitment
J. Biol. Chem., August 30, 2002; 277(36): 33001 - 33011.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
M. Mathur, P. W. Tucker, and H. H. Samuels
PSF Is a Novel Corepressor That Mediates Its Effect through Sin3A and the DNA Binding Domain of Nuclear Hormone Receptors
Mol. Cell. Biol., April 1, 2001; 21(7): 2298 - 2311.
[Abstract] [Full Text]


Home page
Mol. Endocrinol.Home page
C. Rochette-Egly, J.-L. Plassat, R. Taneja, and P. Chambon
The AF-1 and AF-2 Activating Domains of Retinoic Acid Receptor-{alpha} (RAR{alpha}) and Their Phosphorylation Are Differentially Involved in Parietal Endodermal Differentiation of F9 Cells and Retinoid-Induced Expression of Target Genes
Mol. Endocrinol., September 1, 2000; 14(9): 1398 - 1410.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
H. A. Kester, C. Blanchetot, J. den Hertog, P. T. van der Saag, and B. van der Burg
Transforming Growth Factor-beta -stimulated Clone-22 Is a Member of a Family of Leucine Zipper Proteins That Can Homo- and Heterodimerize and Has Transcriptional Repressor Activity
J. Biol. Chem., September 24, 1999; 274(39): 27439 - 27447.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. M. Kraichely, J. J. Collins III, R. K. DeLisle, and P. N. MacDonald
The Autonomous Transactivation Domain in Helix H3 of the Vitamin D Receptor Is Required For Transactivation and Coactivator Interaction
J. Biol. Chem., May 14, 1999; 274(20): 14352 - 14358.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. E. Folkers, B. van der Burg, and P. T. van der Saag
Promoter Architecture, Cofactors, and Orphan Receptors Contribute to Cell-specific Activation of the Retinoic Acid Receptor beta 2 Promoter
J. Biol. Chem., November 27, 1998; 273(48): 32200 - 32212.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
A. Baniahmad, U. Dressel, and R. Renkawitz
Cell-Specific Inhibition of Retinoic Acid Receptor-{alpha} Silencing by the AF2/{tau}c Activation Domain Can Be Overcome by the Corepressor SMRT, But Not by N-CoR
Mol. Endocrinol., April 1, 1998; 12(4): 504 - 512.
[Abstract] [Full Text]


Home page
Mol. Endocrinol.Home page
S.-K. Lee, S.-Y. Na, H.-J. Kim, J. Soh, H.-S. Choi, and J. W. Lee
Identification of Critical Residues for Heterodimerization within the Ligand-Binding Domain of Retinoid X Receptor
Mol. Endocrinol., March 1, 1998; 12(3): 325 - 332.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
J. R. Wilkinson and H. C. Towle
Identification and Characterization of the AF-1 Transactivation Domain of Thyroid Hormone Receptor beta 1
J. Biol. Chem., September 19, 1997; 272(38): 23824 - 23832.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. E. Folkers, E. C. van Heerde, and P. T. van der Saag
Activation Function 1 of Retinoic Acid Receptor beta2 Is an Acidic Activator Resembling VP16
J. Biol. Chem., October 6, 1995; 270(40): 23552 - 23559.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
R Valcarcel, H Holz, C G Jimenez, D Barettino, and H G Stunnenberg
Retinoid-dependent in vitro transcription mediated by the RXR/RAR heterodimer.
Genes & Dev., December 15, 1994; 8(24): 3068 - 3079.
[Abstract] [PDF]


Home page
J. Cell Sci.Home page
J. Frangioni, N Moghal, A Stuart-Tilley, B. Neel, and S. Alper
The DNA binding domain of retinoic acid receptor beta is required for ligand-dependent suppression of proliferation. Application of general purpose mammalian coexpression vectors
J. Cell Sci., January 4, 1994; 107(4): 827 - 838.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1993 by The Endocrine Society